Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
Type:
Grant
Filed:
March 4, 2022
Date of Patent:
October 20, 2026
Assignee:
CREATE Medicines, Inc.
Inventors:
Daniel Getts, Yuxiao Wang, Namita Bisaria
Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.